Robert J. Shovlin, President, Clinical Services at NEOGENOMICS INC (NEO), sold 25,882 shares at $13.12 ($340K) on 2018-06-29, disclosed to the SEC on 2018-06-29.
Open-market sale of $340k NEO by President, Clinical Services. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.12 | 12,941 | $170K | 50.0% |
| 2 | $13.12 | 12,941 | $170K | 50.0% |
| Total | $13.12 avg | 25,882 | $340K | 100% |
| Filing → |
| NEO | SELL | 2020-03-05 | $6.1M | — | Filing → |
| NEO | SELL | 2019-11-04 | $4.9M | — | Filing → |
| NEO | SELL | 2019-05-06 | $5.3M | — | Filing → |